GSK said on Friday that its respiratory syncytial virus (RSV) vaccine has received approval in Japan for expanded use in ...

Learn about this vaccine that protects against a common seasonal virus that can sometimes cause severe disease, with info on ...

Winter and family holiday gatherings often bring a surge in a wide variety of respiratory issues. Here's what to watch for.

COVID-19, influenza, and respiratory syncytial virus (RSV) vaccination coverage is low among adults so far this respiratory ...

Zuo is a public health resident at the University of British Columbia who works with Northern Health’s medical health ...

A new Centers for Disease Control and Prevention (CDC) report reveals low uptake of flu, COVID-19 and respiratory syncytial ...

COVID-19, influenza, and respiratory syncytial virus (RSV) vaccination coverage is low among nursing home residents e ...

GSK has received approval from Japan's MHLW for its application to extend the indication of its RSV vaccine, Arexvy.

Effectiveness of Maternal Vaccination to Prevent Respiratory Syncytial Virus Illness,” published in the November 2024 issue ...

Significant gaps in vaccination coverage among nursing home residents leaves vulnerable populations at risk for severe ...

Respiratory syncytial virus, or RSV, is something many parents know as a cause of bronchiolitis, but others may not have ...

FluMist, a self-administered flu vaccine, is approved for ages 2-49, but will be available in the 2025-2026 season. RSV vaccination is vital for older adults, with new guidelines for those aged 60-74, ...